Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Senju Pharmaceutical Beijing Co. Ltd.
0 Patents (Medical) associated with Senju Pharmaceutical Beijing Co. Ltd.
100 Deals associated with Senju Pharmaceutical Beijing Co. Ltd.
100 Translational Medicine associated with Senju Pharmaceutical Beijing Co. Ltd.